Jan van der Hoeven

Jan is a life sciences investor (Biox Biosciences). He has more than 30 years of experience in private equity-backed life sciences companies in the areas of operations, science and finance. He was co-founder of the CRO NOTOX, which he headed until it was acquired by WIL Research Laboratories in 2006. Jan has served numerous life sciences companies as a member of the supervisory board and has been involved in several successful international mergers and acquisitions. He graduated from Wageningen University as a toxicologist and he is currently active in several funds to stimulate life sciences companies.

Back to about us